Results 141 to 150 of about 14,464 (157)

Ziv-aflibercept is effective in platinum-resistant SCLC

Nature Reviews Clinical Oncology, 2014
exaly   +2 more sources

Ziv-aflibercept: binding to more than VEGF-A—does more matter?

Nature Reviews Clinical Oncology, 2012
The VELOUR and VITAL studies recently demonstrated ziv-aflibercept improved overall survival in patients with metastatic colorectal cancer (mCRC), including those previously treated with bevacizumab, but did not improve overall survival in non-small-cell lung cancer.
Jeffrey M Clarke, Herbert I Hurwitz, Clarke Jeffrey M   +2 more
exaly   +3 more sources

Safety and Efficacy of Ziv-Aflibercept in the Treatment of Refractory Diabetic Macular Edema

Ophthalmic Surgery, Lasers and Imaging Retina, 2017
BACKGROUND AND OBJECTIVE: To evaluate the safety and efficacy of ziv-aflibercept (Zaltrap; Sanofi-Aventis, Bridgewater, NJ/Regeneron Pharmaceuticals, Tarrytown, NY) in the treatment of refractory diabetic macular edema (DME). PATIENTS AND METHODS: Retrospective case series looking ...
Mohammed, Ashraf, Hassan El, Kayal, Ahmed A R, Souka   +2 more
openaire   +2 more sources

Ziv-aflibercept: A novel angiogenesis inhibitor for the treatment of metastatic colorectal cancer

American Journal of Health-System Pharmacy, 2013
Abstract Purpose The pharmacology, pharmacokinetics, clinical efficacy, safety, and administration of ziv-aflibercept in combination therapy for metastatic colorectal cancer (mCRC) are reviewed. Summary Ziv-aflibercept (Zaltrap ...
Clement, Chung, Nisha, Pherwani
openaire   +2 more sources

INTRAVITREAL ZIV-AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Retina, 2019
Purpose: To evaluate the 52-week safety and efficacy of intravitreal ziv-aflibercept in patients with neovascular age-related macular degeneration. Methods: All patients received three monthly intravitreal injections of 0.05 mL of ziv-aflibercept (1.25 mg) followed by a pro re nata ...
João R, de Oliveira Dias, Gabriel, Costa de Andrade, Vinicius F, Kniggendorf, Eduardo A, Novais, Vítor K L, Takahashi, André, Maia, Carsten, Meyer, Sung E S, Watanabe, Michel E, Farah, Eduardo B, Rodrigues   +9 more
openaire   +2 more sources

Ziv-aflibercept

2021
openaire   +1 more source

Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies

Journal of Pharmaceutical and Biomedical Analysis, 2021
Jesus Hermosilla, Raquel Pérez-Robles, Antonio Salmerón-García   +2 more
exaly  

Ziv-aflibercept for Better Regulating Neovascular Age-Related Macular Degeneration (ZEBRA): A Prospective, Randomized Trial

Seminars in Ophthalmology, 2021
Haley S D'Souza, Kapil G Kapoor, Alan L Wagner   +2 more
exaly  

Ziv‐aflibercept: A cost‐effective, off‐label, highly potent antagonist of vascular endothelial growth factor

Acta Ophthalmologica, 2020
Ahmad M Mansour, Michael W Stewart, Michel Eid Farah   +2 more
exaly  

Use of Ziv Aflibercept in Different Retinal Diseases

Case Medical Research, 2020
openaire   +1 more source